Open Access and Peer-reviewed Medical Journal
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal


Case Report Open Access


A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma

Erdinc Nayir.

Abstract
Introduction: Epithelioid Hemangioendothelioma (EHE) is a rarely seen tumor most frequently originating
from vascular structures of different regions including liver, followed by stomach, spleen, lung, bone, soft
tissue, and skin.
Case Presentation: In this paper, a patient with multiple mass lesions in the liver with a diagnosis of EHE who underwent liver transplantation is presented.
Conclusion: It has an intermediate degree of malignancy between benign hemangioma, and malignant hemangiosarcoma. It can manifest with nonspecific symptoms or hepatic failure. Generally it is seen as a diffuse hepatic disease. The most optimal treatment alternatives are liver resection, and transplantation.

Key words: Hemangioendothelioma, liver transplantation, liver tumor


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Erdinc Nayir
on Google
on Google Scholar
Article Statistics
 Viewed: 855
Downloaded: 371
Cited: 0


REFERENCES
1. Dong K, Wnag X, Feng JL et al. Pathological characteristics of liver biopsies in eight patients with hepatic epithelioid hemangio endothelioma. Int J Clin Exp Pathol 2015;8(9): 11015-23. [Pubmed]    [PMC Free Fulltext]   
2. Pregliasco AG, Wendum D, Goumard C et al. Hepatic epithelioid hemangioendothelioma. Clin Res Hepatol Gastroenterol 2015 Nov 3. pii: S2210-7401(15)00254-5.
3. Mehrabi A, Kashfi A, Fonouni H et al. Primary malignant hepatic epithelioid hemangioendothelioma: A comprehensive rewiew of the literature with emphasis on the surgical therapy. Cancer 2006;107:2108-21. [DOI via Crossref]    [Pubmed]   
4. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: A vascular tumor often mistaken for a carcinoma. Cancer 1982;50:970-81 . [DOI via Crossref]   
5. Sangro B, Inaarrairaegui M, Fernandez-Ros N. Malignant epitheloid hemangioendothelioma of the liver successfully treated with sorafenib. Rare Tumors 2012;4:e34 . [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
6. Caruso S, Miraglia R, Maruzelli L et al. An unusual presentation of malignant hepatic epithelioid hemangioendothelioma with left pleural and pulmonary localization.Pediatr Radiol 2008;38:1027-30 [DOI via Crossref]    [Pubmed]   
7. Ji ZF, Shen XZ, Zhang DY et al. Hepatic epithelioid hemangio endothelioma: a report of six patients. J Dig Dis 2010;11:254-8. [Pubmed]   
8. Tsuneyoshi M, Dorfman HD, Bauer TW. Epithelioid hemangio endothelioms of bone: a clinicopathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 1986;10:754-64. [DOI via Crossref]    [Pubmed]   
9. Langrehr JM, Petersen I, Pfitzmann R, Lopez-Hanninen E. Malignant epithelioid hemangioendothelioma of the liver. Result of surgical treatment strategies. Chirurg 2005;76:1161-7. [DOI via Crossref]    [Pubmed]   
10. Lerut JP, Orlando G, Sempoux C et al. Hepatic hemangio endothelioma in adults: Excellent outcome following liver transplantation. Transpl Int 2004;17:202-07. [DOI via Crossref]    [Pubmed]   
11. Ben-Haim M, Roayaise S, Ye MQ et al. Hepatic epithelioid hemangioendothelioma: Resection or transplantation, which and when? Liver Transpl Surg 1999;5:526-31. [DOI via Crossref]    [Pubmed]   
12. Lerut JP, Orlando G, Adam R. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg. 2007 Dec;246(6):949-57. [DOI via Crossref]    [Pubmed]   

How to Cite this Article
Pubmed Style

Erdinc Nayir. A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma. Ulutas Med J. 2016; 2(1): 59-62. doi:10.5455/umj.20160121062843


Web Style

Erdinc Nayir. A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma. http://www.ulutasmedicaljournal.com/?mno=214641 [Access: December 11, 2017]. doi:10.5455/umj.20160121062843


AMA (American Medical Association) Style

Erdinc Nayir. A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma. Ulutas Med J. 2016; 2(1): 59-62. doi:10.5455/umj.20160121062843



Vancouver/ICMJE Style

Erdinc Nayir. A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma. Ulutas Med J. (2016), [cited December 11, 2017]; 2(1): 59-62. doi:10.5455/umj.20160121062843



Harvard Style

Erdinc Nayir (2016) A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma. Ulutas Med J, 2 (1), 59-62. doi:10.5455/umj.20160121062843



Turabian Style

Erdinc Nayir. 2016. A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma. THE ULUTAS MEDICAL JOURNAL, 2 (1), 59-62. doi:10.5455/umj.20160121062843



Chicago Style

Erdinc Nayir. "A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma." THE ULUTAS MEDICAL JOURNAL 2 (2016), 59-62. doi:10.5455/umj.20160121062843



MLA (The Modern Language Association) Style

Erdinc Nayir. "A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma." THE ULUTAS MEDICAL JOURNAL 2.1 (2016), 59-62. Print. doi:10.5455/umj.20160121062843



APA (American Psychological Association) Style

Erdinc Nayir (2016) A Rarely Seen Hepatic Tumor: Epithelioid Hemangioendothelioma. THE ULUTAS MEDICAL JOURNAL, 2 (1), 59-62. doi:10.5455/umj.20160121062843








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


CrossRef

ScopeMed

Google Scholar

TUBITAK Dergipark

Index Scholar

Index Copernicus


ABOUT JOURNAL
POLICIES and STATEMENTS

The articles in Ulutas Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.